EUVIMEDEUVIMED entdecken
Crossref

RNA Splicing of the FGFR2 Gene Promotes Endothelial Cell Senescence and Atherosclerosis Development

Qihong Ni, Haozhe Qi iD, Yinteng Chu iD, Ruzhou Cao iD, Yuli Wang iD, Shuofei Yang iD, Yongjie Yao iD, Hai Wang iD, Kai Yuan iD, Lei Lv iD, Meng Ye iD, Guanhua Xue iD und 3 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.125.323834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Qihong Ni und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, China. Hauptthemen laut MEDLINE: Cellular Senescence, Atherosclerosis, Receptor, Fibroblast Growth Factor, Type 2, Alternative Splicing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Endothelial cell (EC) senescence is intimately linked to the development and progression of atherosclerosis. The FGFR2 (fibroblast growth factor receptor 2) signaling is crucial in regulating the phenotype of ECs. Recent studies have revealed that cell phenotype–specific alternative splicing of FGFR2 premRNA (precursor mRNA) results in the mutually exclusive inclusion of either exon IIIb or IIIc, leading to critical differences in receptor function. This study aimed to investigate the role of FGFR2 alternative splicing in EC senescence and atherosclerosis development, and to elucidate the underlying mechanisms. METHODS: Clinical samples and animal models were used to assess the association between FGFR2-IIIc isoform expression and EC senescence as well as atherosclerotic plaque formation. The mechanisms underlying FGFR2-IIIc–induced EC senescence were elucidated through a combination of in vivo and in vitro investigations. In addition, genetically engineered mice with endothelial-specific overexpression or knockdown of FGFR2-IIIc were utilized to investigate the impact of FGFR2-IIIc on vascular endothelial senescence and the progression of atherosclerosis. RESULTS: Elevated expression of the FGFR2-IIIc isoform was detected in clinical samples and animal models of aging and atherosclerosis, where it correlated with both EC senescence and atherosclerotic plaque formation. Mechanistically, the alternative splicing–mediated switch from FGFR2-IIIb to FGFR2-IIIc established an FGF2–FGFR2-IIIc autocrine feedback loop, which drove ECs toward a senescence-associated secretory phenotype via the PKC (protein kinase C) ε/STAT3 (signal transducer and activator of transcription) pathway. Senescence-inducing stimuli promoted the binding of the splicing factor hnRNP H1 (heterogeneous nuclear ribonucleoprotein H1) to exon IIIb of the FGFR2 gene, leading to skipping of this exon. Notably, EC-specific knockout of FGFR2-IIIc in ApoE −/− mice reduced plaque area, suppressed senescence-associated secretory phenotype gene expression, and attenuated cellular senescence compared with controls. CONCLUSIONS: This study reveals that FGFR2 splicing mediated by hnRNP H1 promotes EC senescence and atherosclerosis via an FGF2–FGFR2-IIIc autocrine loop. These findings identify FGFR2-IIIc as a potential therapeutic target for age-related atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceAtherosclerosisReceptor, Fibroblast Growth Factor, Type 2Alternative SplicingEndothelial CellsAnimalsHumansPlaque, AtheroscleroticSignal TransductionDisease Models, AnimalMice, Inbred C57BLSTAT3 Transcription FactorMaleCells, CulturedPhenotypeMice, Knockout, ApoEHuman Umbilical Vein Endothelial CellsExons

Stichwörter der Autor:innen

alternative splicingatherosclerosisendothelial cellsreceptor, fibroblast growth factor, type 2senescence-associated secretory phenotype

Substanzen

Receptor, Fibroblast Growth Factor, Type 2FGFR2 protein, humanSTAT3 Transcription FactorFgfr2 protein, mouseSTAT3 protein, humanStat3 protein, mouse

Autor:innen und Institutionen

  • Department of Vascular Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, China.

ORCID-Profile: Haozhe Qi, Yinteng Chu, Ruzhou Cao, Yuli Wang, Shuofei Yang, Yongjie Yao, Hai Wang, Kai Yuan, Lei Lv, Meng Ye, Guanhua Xue, Lan Zhang, Xiangjiang Guo, Yinan Li

Zitieren

APA

Ni, Q., Qi, H., Chu, Y., Cao, R., Wang, Y., Yang, S., Yao, Y., Wang, H., Yuan, K., Lv, L., Ye, M., Xue, G., Zhang, L., Guo, X., & Li, Y. (2026). RNA Splicing of the FGFR2 Gene Promotes Endothelial Cell Senescence and Atherosclerosis Development. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323834

Vancouver

Ni Q, Qi H, Chu Y, Cao R, Wang Y, Yang S, et al. RNA Splicing of the FGFR2 Gene Promotes Endothelial Cell Senescence and Atherosclerosis Development. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.323834

BibTeX
@article{Ni2026,
  author = {Ni, Qihong and Qi, Haozhe and Chu, Yinteng and Cao, Ruzhou and Wang, Yuli and Yang, Shuofei and Yao, Yongjie and Wang, Hai and Yuan, Kai and Lv, Lei and Ye, Meng and Xue, Guanhua and Zhang, Lan and Guo, Xiangjiang and Li, Yinan},
  title = {RNA Splicing of the FGFR2 Gene Promotes Endothelial Cell Senescence and Atherosclerosis Development},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.125.323834}
}
Kostenlos starten →